No matter how cynical the overall market is, OmniAb Inc (OABI) performance over the last week is recorded -16.45%

A new trading day began on Tuesday, with OmniAb Inc (NASDAQ: OABI) stock price down -8.85% from the previous day of trading, before settling in for the closing price of $2.09. OABI’s price has ranged from $1.90 to $5.45 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 1.70% over the last five years. Meanwhile, its annual earnings per share averaged 2.05%. With a float of $97.82 million, this company’s outstanding shares have now reached $121.60 million.

The firm has a total of 114 workers. Let’s measure their productivity. In terms of profitability, gross margin is 16.26%, operating margin of -282.3%, and the pretax margin is -270.59%.

OmniAb Inc (OABI) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of OmniAb Inc is 19.16%, while institutional ownership is 53.62%. The most recent insider transaction that took place on Apr 07 ’25, was worth 38,764. In this transaction President and CEO of this company sold 19,382 shares at a rate of $2.00, taking the stock ownership to the 3,796,236 shares. Before that another transaction happened on Apr 07 ’25, when Company’s Chief Legal Officer sold 7,206 for $2.00, making the entire transaction worth $14,412. This insider now owns 363,212 shares in total.

OmniAb Inc (OABI) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 2.05% per share during the next fiscal year.

OmniAb Inc (NASDAQ: OABI) Trading Performance Indicators

Here are OmniAb Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.52. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.82.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.49 in one year’s time.

Technical Analysis of OmniAb Inc (OABI)

Analysing the last 5-days average volume posted by the [OmniAb Inc, OABI], we can find that recorded value of 0.63 million was better than the volume posted last year of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 17.79%. Additionally, its Average True Range was 0.17.

During the past 100 days, OmniAb Inc’s (OABI) raw stochastic average was set at 0.73%, which indicates a significant decrease from 2.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.54% in the past 14 days, which was higher than the 65.55% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.11, while its 200-day Moving Average is $3.81. Now, the first resistance to watch is $2.09. This is followed by the second major resistance level at $2.27. The third major resistance level sits at $2.38. If the price goes on to break the first support level at $1.80, it is likely to go to the next support level at $1.69. Now, if the price goes above the second support level, the third support stands at $1.51.

OmniAb Inc (NASDAQ: OABI) Key Stats

With a market capitalization of 232.67 million, the company has a total of 122,135K Shares Outstanding. Currently, annual sales are 26,390 K while annual income is -62,030 K. The company’s previous quarter sales were 10,800 K while its latest quarter income was -13,070 K.